Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTEM vs FOLFIRI in MGMT methylated, RAS mutated metastatic colorectal cancer
NCT02414009Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Sep 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in metastatic colorectal cancer (mCRC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Sep 2014; status: completed.
02
Drugs
temozolomide
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02414009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414009.